The U.S. Food and Drug Administration (FDA) reportedly blocked the publication of research indicating the safety of COVID-19 and shingles vaccines. This revelation emerges as the agency contemplates imposing the strongest "Black Box Warning" on COVID-19 vaccines and plans to raise regulatory hurdles for immunizations, citing concerns over COVID shots linked to ten children's deaths. These developments coincide with significant leadership transitions within the FDA's vaccine and biologics unit.

JKN Global News Desk reports that the U.S. Food and Drug Administration reportedly impeded the publication of studies that found both COVID-19 and shingles vaccines to be safe, according to reports from The New York Times and Reuters. This action draws attention as the agency concurrently faces increasing pressure regarding vaccine safety and regulatory oversight.

In a significant move, the FDA is reportedly weighing the implementation of its strongest "Black Box Warning" for COVID-19 vaccines, as reported by Vaccine Advisor. Furthermore, NPR states that the agency plans to increase regulatory hurdles for vaccines, specifically faulting COVID-19 shots for the deaths of ten children. Amid this heightened scrutiny, Moderna is reportedly in discussions with the FDA concerning post-marketing COVID shot data, with the aim of achieving wider access for its vaccine.

These critical developments unfold amidst a turbulent period for the FDA's Center for Biologics Evaluation and Research (CBER), which oversees vaccines. The Hill and BioSpace report that the FDA has named Katherine Szarama as the acting director for its vaccines and biologics unit, following the tumultuous tenure of her predecessor, who had previously stepped down. The Santa Clarita Valley Signal also noted that a top FDA vaccine official stepped down again, with a deputy assuming control. Internally, FDA Chief Marty Makary is reportedly "on thin ice" with the White House, according to NOTUS — News of the United States. Adding to the complexity, a CIDRAP report highlighted an FDA official proposing "impossible" standards for vaccine testing, which could potentially curtail access to immunizations.